Front Cover Image, Volume 46, Issue 3

Key Points

• The aim is to explore the IL-23/IL-17/NF-κB signaling pathway and its role in rheumatoid arthritis.
• Review of molecular mechanisms involved in the signaling pathway.
• Examination of therapeutic agents targeting these pathways.
• Analysis of their effects on rheumatoid arthritis.
• Identified key molecular mechanisms associated with rheumatoid arthritis progression.
• Discussed potential therapeutic agents targeting the IL-23/IL-17/NF-κB pathway.
• Highlighted implications for future treatments and patient outcomes.

Abstract